The German company said its outside experts found “material breaches” of FDA standards while reviewing Akorn's operations.
from nicholemhearn digest http://www.chicagobusiness.com/article/20180423/NEWS03/180429979/fresenius-walks-away-from-akorn-deal?utm_source=NEWS03&utm_medium=rss&utm_campaign=chicagobusiness
No comments:
Post a Comment